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Implications of myocardial reperfusion on survival in women versus 
men with acute myocardial infarction undergoing primary coronary 
intervention
Rahil Hamdadou, Mohamed Chettibi, Redouane Nedjar, Mohamed Tahar 
Bouafia
CHU Frantz Fanon, Cardiologie, Blida, Algérie
Background: The in hospital mortality rate after myocardial infarction is 
higher among women than men. PCI is recommended treatment for ST -seg-
ment elevation myocardial infarction (STEMI) in patients of both genders. It 
is used in women without a clear demonstration of their efficiency in this 
population. It is only extrapolations of studies enrolling a large majority of 
males (more than 85%).It is very important to improve our therapeutic straté-
gies in women, to perform dedicated studies.
Aim: Of our study was to compare clinical and angiographic features in 
men and women and to determine wether gender influenced in – hospital 
prognosis of primary percutaneous coronary intervention.
Methods: We conducted a retrospective study including 282 patients 
admitted in the University hospital of Blida (Alegria). Between April 2009 
and January 2011. All these patients had an ST segment elevation myocardial 
infarction and underwent primary PCI within 12 hours after symptom onset.
Results: Our population counted 239men and 43women. Females were 
significantly older (p<0.05).They had a higher prevalence of diabetes 32.6% 
(P<0.05), hypertension 55.8% (P=0.01), dyslipemia16.3% (P<0.05). They were 
more likely to consult late (Mean time from symptom onset was 299.7±93.9min 
in women vs 296±97.9mn in men (p<0.001). In our study, angiographic success 
was achieved in 76.7% of the cases in women and in 92.1% of the cases in men 
(p=0.005).The in hospital mortality rate was 7% in women and 5% in men 
(p=NS).
Conclusion: There is no gender descrepancy in – hospital mortality in 
patients who undergo emergency PCI for treatment of STEMI. These data 
suggest that gender should not affect the decision to offer PCI but further 
gender specific studies are warranted.
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Relationship of hyperglycemia to the no-reflow phenomenon in ST-
elevation myocardial infarction patients treated by primary percuta-
neous coronary intervention
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Background: It has been shown that elevated blood glucose levels on 
admission are associated with worse outcome in ST elevation myocardial 
infarction.
Impaired microvascular function and no-reflow phenomenon seem to be 
one of the underlying mechanisms of hyperglycemia deleterious effects
Aim: To establish the relationship between hyperglycemia on admission 
and the no-reflow phenomenon
Methods: Patients presenting with acute STEMI who underwent primary 
percutaneous coronary intervention (PCI) were enrolled. ST segment resolu-
tion was evaluated at 90 minutes in the worst lead. No-reflow was defined as 
a resolution of ST segment less than 50% in the worst lead at 90 minutes
Results: 102 consecutive patients were enrolled (87 men and 15 women) 
with a mean age of 56.95 ±12.89 years. The no-reflow phenomenon was 
observed in 28 (27.45 %) patients, their glucose level on hospital admission 
was significantly higher than in patients whithout no-reflow phenomenon 
(12.48 ± 7.48 vs. 8.55 ± 2.27 mmol/l; p = 0.01). Multivariate analysis showed 
that hyperglycemia defined as glycemia >11mmol/L was an independent pre-
dictor factor for no-reflow (OR = 2.18, CI = 1.42 – 3.84; p = 0.002)
Conclusion: Hyperglycemia on admission is associated with higher risk of 
no-reflow in STEMI patients undergoing primary PCI.
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Relationship between balloon release pressure and ST resolution in 
STEMI patients undergoing primary PCI
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Background: The optimal balloon release pressure in primary percuta-
neous coronary intervention is not well established and use of high pressure 
may jeopardize ST resolution and increase the occurrence of no reflow.
Aim: To investigate the relationship between balloon release pressure and 
ST resolution in STEMI patients undergoing primary PCI.
Methods: Patients undergoing primary PCI for ST elevation myocardial 
infarction were enrolled and assigned into two groups according to the stent 
implantation pressure. High pressure group with a pressure >16 atm. Standard 
pressure <16 atm. The balloon pressure release was left to the operators’ dis-
cretion. No-reflow phenomenon was defined as Σ ST-segment resolution 
<70%
Results: 137 patients were enrolled with a mean age of 56.39 ± 12.8 years. 
The results showed that no-reflow phenomenon occurred more frequently in 
the high pressure group 49.32% vs 27%; p = 0.002. Furthermore, the high 
pressure group showed less ST resolution than the low pressure group with a 
mean ST-resolution 60.43 ± 25.86 vs 72.35 ± 18.13; p = 0.001
Conclusion: In primary PCI when stenting the culprit lesion, low pressure 
release may be better in avoiding the no reflow phenomenon
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Prevalence of glucose disoders in a cohort of patients hospitalized for 
ACS in coronary care unit, and security and efficiency of an intra-
veinous insulin protocol adapted on glycemic kinetic
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Background: Glycemic variabilities have a negative impact on the mor-
bidity and mortality of acute coronary syndromes (ACS). A strict glucose 
monitoring is recommended on admission in Coronary Care Unit (CCU). The 
aims of our study were to assess the prevalence of various glucose disorders 
(diabete mellitus, impared fasting hyperglycemia, glucose intolerance, stress 
hyperglycemia) among patients hospitalized for ACS, and to assess the effi-
cency and security of an IV insulin protocol adapted on glycemic kinetic, to 
decrease the risk of hypoglycemia, and for which the goal was to stabilized 
glycemia between 1.10 and 1,40g/l.
Population and Method: This retrospective monocenter study concerns 
all patients admitted for ACS (STEMI and NSTEMI) in Troyes hospital from 
May 2012 to May 2013. The different glycemic parameters, capillarious and 
veinous were collect through analysis of medical reports.
Results: 164 patients were included. The mean age was 65 ± 13 years. 
Among them, 97 (59%) had diabete mellitus, and 8 (5%) had an intermediate 
disorder. Stress hyperglycemia was observed in 10 patients (11%) free from glu-
cose abnormalities. Among the patients without hystory of diabete mellitus and 
with hyperglycemia on admission, 53% were authentic diabetics. The IV insulin 
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